» Articles » PMID: 29886854

Underlying Trend, Seasonality, Prediction, Forecasting and the Contribution of Risk Factors: an Analysis of Globally Reported Cases of Middle East Respiratory Syndrome Coronavirus

Overview
Date 2018 Jun 12
PMID 29886854
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

This study set out to identify and analyse trends and seasonal variations of monthly global reported cases of the Middle East respiratory syndrome coronavirus (MERS-CoV). It also made a prediction based on the reported and extrapolated into the future by forecasting the trend. Finally, the study assessed contributions of various risk factors in the reported cases. The motivation for this study is that MERS-CoV remains among the list of blueprint priority and potential pandemic diseases globally. Yet, there is a paucity of empirical literature examining trends and seasonality as the available evidence is generally descriptive and anecdotal. The study is a time series analysis using monthly global reported cases of MERS-CoV by the World Health Organisation between January 2015 and January 2018. We decomposed the series into seasonal, irregular and trend components and identified patterns, smoothened series, generated predictions and employed forecasting techniques based on linear regression. We assessed contributions of various risk factors in MERS-CoV cases over time. Successive months of the MERS-CoV cases suggest a significant decreasing trend (P = 0.026 for monthly series and P = 0.047 for Quarterly series). The MERS-CoV cases are forecast to wane by end 2018. Seasonality component of the cases oscillated below or above the baseline (the centred moving average), but no association with the series over time was noted. The results revealed contributions of risk factors such as camel contact, male, old age and being from Saudi Arabia and Middle East regions to the overall reported cases of MERS-CoV. The trend component and several risk factors for global MERS-CoV cases, including camel contact, male, age and geography/region significantly affected the series. Our statistical models appear to suggest significant predictive capacity and the findings may well inform healthcare practitioners and policymakers about the underlying dynamics that produced the globally reported MERS-CoV cases.

Citing Articles

The transmission dynamics of Middle East Respiratory Syndrome coronavirus.

Rui J, Wang Q, Lv J, Zhao B, Hu Q, Du H Travel Med Infect Dis. 2021; 45:102243.

PMID: 34954112 PMC: 8694792. DOI: 10.1016/j.tmaid.2021.102243.


Coronavirus seasonality, respiratory infections and weather.

Nichols G, Gillingham E, Macintyre H, Vardoulakis S, Hajat S, Sarran C BMC Infect Dis. 2021; 21(1):1101.

PMID: 34702177 PMC: 8547307. DOI: 10.1186/s12879-021-06785-2.


Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases.

Jonkmans N, DAcremont V, Flahault A BMJ Glob Health. 2021; 6(9).

PMID: 34531189 PMC: 8449939. DOI: 10.1136/bmjgh-2021-006623.


Combining probabilistic forecasts of COVID-19 mortality in the United States.

Taylor J, Taylor K Eur J Oper Res. 2021; 304(1):25-41.

PMID: 34219901 PMC: 8236414. DOI: 10.1016/j.ejor.2021.06.044.


SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions.

Abdelghany T, Ganash M, Bakri M, Qanash H, Al-Rajhi A, Elhussieny N Biomed J. 2021; 44(1):86-93.

PMID: 33602634 PMC: 7603957. DOI: 10.1016/j.bj.2020.10.008.


References
1.
Sherbini N, Iskandrani A, Kharaba A, Khalid G, Abduljawad M, Al-Jahdali H . Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: Demographic, clinical and survival data. J Epidemiol Glob Health. 2016; 7(1):29-36. PMC: 7104069. DOI: 10.1016/j.jegh.2016.05.002. View

2.
Harriman K, Brosseau L, Trivedi K . Hospital-associated Middle East respiratory syndrome coronavirus infections. N Engl J Med. 2013; 369(18):1761. DOI: 10.1056/NEJMc1311004. View

3.
Corman V, Albarrak A, Omrani A, Albarrak M, Farah M, Almasri M . Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection. Clin Infect Dis. 2015; 62(4):477-483. PMC: 7108065. DOI: 10.1093/cid/civ951. View

4.
Choi W, Kang C, Kim Y, Choi J, Joh J, Shin H . Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea. Infect Chemother. 2016; 48(2):118-26. PMC: 4945721. DOI: 10.3947/ic.2016.48.2.118. View

5.
Banik G, Alqahtani A, Booy R, Rashid H . Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia. Virol Sin. 2016; 31(1):81-4. PMC: 7090713. DOI: 10.1007/s12250-015-3679-z. View